First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: Results of a retrospective claims review

Clinical Therapeutics

Volumn 31, Issue 6, 2009, Pages 1309-1320

  Sung, Si Kyung ^a   Lee, Sok Goo ^b   Lee, Kun Sei ^c,d   Kim, Dong Sook ^d   Kim, Kyoung Hoon ^d   Kim, Keon Yeop ^e  

^a Daejeon University   (South Korea)

^b Chungnam National University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Health Insurance Review Agency   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

Author keywords

associated factors; cumulative medication adherence (CMA); hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BILLING AND CLAIMS; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; FAMILY MEDICINE; FEMALE; GENERAL HOSPITAL; HUMAN; HYPERTENSION; INTERNAL MEDICINE; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTPATIENT CARE; PATIENT COMPLIANCE; PHYSICIAN; PRESCRIPTION; PRIVATE HOSPITAL; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; REVIEW; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; KOREA; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; OUTPATIENTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 68649085684     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.06.011     Document Type: Review

References (31)

1. Chobanian A.V., Bakris G.L., Black H.R., et al., the National Heart, Lung, Blood Institute Joint National Committee on Prevention, Detection, Evaluation, Treatment of High Blood Pressure, the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report [published correction appears in JAMA. 2003;290:197]. JAMA 289 (2003) 2560-2572
2. Moore M.A. Drugs that interrupt the renin-angiotensin system should be among the preferred initial drugs to treat hypertension. J Clin Hypertens (Greenwich) 5 (2003) 137-144
3. Hypertension. In: Sabaté E., and the World Health Organization (Eds). Adherence to Long-Term Therapies: Evidence for Action (2003), World Health Organization, Geneva, Switzerland 107-114
4. Bittar N. Maintaining long-term control of blood pressure: The role of improved compliance. Clin Cardiol. 18 Suppl 3 (1995) III12-III16
5. Vlasnik J.J., Aliotta S.L., and DeLor B. Medication adherence: Factors influencing compliance with prescribed medication plans. Case Manager 16 (2005) 47-51
6. In-Depth Analysis on the 3rd (2005) Korea Health and Nutrition Examination Survey-Health Examination (2007), Korea Centers for Disease Control and Prevention, Seoul, Korea
7. Krousel-Wood M., Thomas S., Muntner P., and Morisky D. Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 19 (2004) 357-362
8. Wetzels G.E., Nelemans P., Schouten J.S., and Prins M.H. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: A systematic review. J Hypertens 22 (2004) 1849-1855
9. Gill J.M., and Mainous III A.G. The role of provider continuity in preventing hospitalizations. Arch Fam Med. 7 (1998) 352-357
10. McCombs J.S., Nichol M.B., Newman C.M., and Sclar D.A. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care 32 (1994) 214-226
11. Frishman W.H. Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiol Rev. 15 (2007) 257-263
12. Iskedjian M., Einarson T.R., MacKeigan L.D., et al. Relationship between daily dose frequency and adherence to anti-hypertensive pharmacotherapy: Evidence from a meta-analysis. Clin Ther. 24 (2002) 302-316
13. Steiner J.F., Robbins L.J., Roth S.C., and Hammond W.S. The effect of prescription size on acquisition of maintenance medications. J Gen Intern Med. 8 (1993) 306-310
14. Borghi C., Veronesi M., Dormi A., et al. Persistence of treatment and blood pressure control in elderly hypertensive patients treated with different classes of antihypertensive drugs. Am J Geriatr Cardiol. 16 (2007) 280-286
15. Dezii C.M. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care 9 Suppl 9 (2000) 2-6
16. Marentette M.A., Gerth W.C., Billings D.K., and Zarnke K.B. Antihypertensive persistence and drug class. Can J Cardiol. 18 (2002) 649-656
17. Prandin M.G., Cicero A.F., Veronesi M., et al. Persistence on treatment and blood pressure control with different first-line antihypertensive treatments: A prospective evaluation. Clin Exp Hypertens 29 (2007) 553-562
18. Gerbino P.P., and Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health Syst Pharm. 64 (2007) 1279-1283
19. Scholze J., Bida M., Hansen A., et al. Initiation of hypertension treatment with a fixed-dose combination or its monocomponents-does it really matter?. Int J Clin Pract. 60 (2006) 265-274
20. Knight E.L., Bohn R.L., Wang P.S., et al. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension 38 (2001) 809-814
21. Park J.H., Shin Y., Lee S.Y., and Lee S.I. Anti-hypertensive drug medication adherence and its affecting factors in South Korea. Int J Cardiol. 128 (2008) 392-398
22. Groll D.L., To T., Bombardier C., and Wright J.G. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 58 (2005) 595-602
23. Conlin P.R., Gerth W.C., Fox J., et al. Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other anti-hypertensive drug classes. Clin Ther. 23 (2001) 1999-2010
24. Caro J.J., Salas M., Speckman J.L., et al. Persistence with treatment for hypertension in actual practice. CMAJ 160 (1999) 31-37
25. Fortin M., Hudon C., Dubois M.F., et al. Comparative assessment of three different indices of multimorbidity for studies on health-related quality of life. Health Qual Life Outcomes 3 (2005) 74
26. Korean National Health Insurance Corporation. NHI program and social security program. http://www.nhic.or.kr/eng Accessed December 1, 2008
27. Fortin M., Dubois M.F., Hudon C., et al. Multimorbidity and quality of life: A closer look. Health Qual Life Outcomes 5 (2007) 52
28. Grymonpre R., Cheang M., Fraser M., et al. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care 44 (2006) 471-477
29. Grant R.W., Singer D.E., and Meigs J.B. Medication adherence before an increase in antihypertensive therapy: A cohort study using pharmacy claims data. Clin Ther. 27 (2005) 773-781
30. Steiner J.F., and Prochazka A.V. The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol 50 (1997) 105-116
31. Yakovlevitch M., and Black H.R. Resistant hypertension in a tertiary care clinic. Arch Intern Med. 151 (1991) 1786-1792